1. Executive Summary 2. Immuno-Oncology Drugs Market Characteristics
3. Immuno-Oncology Drugs Market Trends And Strategies
4. Immuno-Oncology Drugs Market – Macro Economic Scenario
4.1 COVID-19 Impact On Immuno-Oncology Drugs Market
4.2 Ukraine-Russia War Impact On Immuno-Oncology Drugs Market
4.3 Impact Of High Inflation On Immuno-Oncology Drugs Market
5. Immuno-Oncology Drugs Market Size And Growth
5.1. Global Immuno-Oncology Drugs Historic Market, 2017-2022, $ Billion
5.1.1. Drivers Of The Market
5.1.2. Restraints On The Market
5.2. Global Immuno-Oncology Drugs Forecast Market, 2022-2027F, 2032F, $ Billion
5.2.1. Drivers Of The Market
5.2.2. Restraints On the Market
6. Immuno-Oncology Drugs Market Segmentation
6.1. Global Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Monoclonal Antibodies
Immune Checkpoint Inhibitors
Immune System Modulators
Cancer Vaccines
Other Types
6.2. Global Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Melanoma
Lung Cancer
Blood Cancer
Renal Cell Carcinoma
Prostate Cancer
Bladder Cancer
Other Applications
6.3. Global Immuno-Oncology Drugs Market, Segmentation By End-user, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Hospitals
Clinics
Ambulatory Surgical Centers
Cancer Research Institutes
7. Immuno-Oncology Drugs Market Regional And Country Analysis
7.1. Global Immuno-Oncology Drugs Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
7.2. Global Immuno-Oncology Drugs Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
8. Asia-Pacific Immuno-Oncology Drugs Market
8.1. Asia-Pacific Immuno-Oncology Drugs Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
8.3. Asia-Pacific Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
9. China Immuno-Oncology Drugs Market
9.1. China Immuno-Oncology Drugs Market Overview
9.2. China Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
9.3. China Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
10. India Immuno-Oncology Drugs Market
10.1. India Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
10.2. India Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
11. Japan Immuno-Oncology Drugs Market
11.1. Japan Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
11.2. Japan Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
12. Australia Immuno-Oncology Drugs Market
12.1. Australia Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
12.2. Australia Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
13. Indonesia Immuno-Oncology Drugs Market
13.1. Indonesia Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
13.2. Indonesia Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
14. South Korea Immuno-Oncology Drugs Market
14.1. South Korea Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
14.2. South Korea Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
15. Western Europe Immuno-Oncology Drugs Market
15.1. Western Europe Immuno-Oncology Drugs Market Overview
15.2. Western Europe Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
15.3. Western Europe Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
16. UK Immuno-Oncology Drugs Market
16.1. UK Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
16.2. UK Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
17. Germany Immuno-Oncology Drugs Market
17.1. Germany Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
17.2. Germany Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
18. France Immuno-Oncology Drugs Market
18.4. France Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
18.5. France Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
19. Eastern Europe Immuno-Oncology Drugs Market
19.1. Eastern Europe Immuno-Oncology Drugs Market Overview
19.2. Eastern Europe Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
19.3. Eastern Europe Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
20. Russia Immuno-Oncology Drugs Market
20.1. Russia Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
20.2. Russia Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
21. North America Immuno-Oncology Drugs Market
21.1. North America Immuno-Oncology Drugs Market Overview
21.2. North America Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
21.3. North America Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
22. USA Immuno-Oncology Drugs Market
22.1. USA Immuno-Oncology Drugs Market Overview
22.2. USA Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
22.3. USA Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
23. South America Immuno-Oncology Drugs Market
23.1. South America Immuno-Oncology Drugs Market Overview
23.2. South America Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
23.3. South America Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
24. Brazil Immuno-Oncology Drugs Market
24.1. Brazil Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
24.2. Brazil Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
25. Middle East Immuno-Oncology Drugs Market
25.1. Middle East Immuno-Oncology Drugs Market Overview
25.2. Middle East Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
25.3. Middle East Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
26. Africa Immuno-Oncology Drugs Market
26.1. Africa Immuno-Oncology Drugs Market Overview
26.2. Africa Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
26.3. Africa Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
27. Immuno-Oncology Drugs Market Competitive Landscape And Company Profiles
27.1. Immuno-Oncology Drugs Market Competitive Landscape
27.2. Immuno-Oncology Drugs Market Company Profiles
27.2.1. Amgen, Inc.
27.2.1.1. Overview
27.2.1.2. Products and Services
27.2.1.3. Strategy
27.2.1.4. Financial Performance
27.2.2. AstraZeneca Plc
27.2.2.1. Overview
27.2.2.2. Products and Services
27.2.2.3. Strategy
27.2.2.4. Financial Performance
27.2.3. Bristol-Myers Squibb
27.2.3.1. Overview
27.2.3.2. Products and Services
27.2.3.3. Strategy
27.2.3.4. Financial Performance
27.2.4. Celgene Corporation
27.2.4.1. Overview
27.2.4.2. Products and Services
27.2.4.3. Strategy
27.2.4.4. Financial Performance
27.2.5. Eli Lilly and Company
27.2.5.1. Overview
27.2.5.2. Products and Services
27.2.5.3. Strategy
27.2.5.4. Financial Performance
28. Immuno-Oncology Drugs Pipeline Analysis
29. Key Mergers And Acquisitions In The Immuno-Oncology Drugs Market
30. Immuno-Oncology Drugs Market Future Outlook and Potential Analysis
31. Appendix
31.1. Abbreviations
31.2. Currencies
31.3. Historic And Forecast Inflation Rates
31.4. Research Inquiries
31.5. The Business Research Company
31.6. Copyright And Disclaimer